Skip to content Skip to footer

RUSSIA’S SPUTNIK V VACCINE IS 91.6% EFFECTIVE AGAINST SYMPTOMATIC COVID-19, INTERIM TRIAL RESULTS SUGGEST

By Zamira Rahim, CNN Updated 1433 GMT (2233 HKT) February 2, 2021 After criticism last year for an early rollout, Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19 and 100% effective against severe and moderate disease, according to an interim analysis of the vaccine's Phase 3 trial results. The preliminary…

Read more

NASAL SOLUTION MAY STOP SPREAD OF COVID-19, STUDY FINDS

Lab tests shows the nasal solution Halodine inactivates COVID-19, suggesting it could be used to stop spread of the coronavirus. A commercially available nasal antiseptic solution "inactivates" COVID-19 just 15 seconds after the coronavirus is exposed to it, effectively preventing the infection from developing, according to a study published Thursday by JAMA Otolaryngology-Head…

Read more

RUSSIA’S PIONEERING SPUTNIK V COVID-19 VACCINE SENT TO GENEVA FOR APPROVAL FROM WORLD HEALTH ORGANIZATION (WHO)

The creators of Sputnik V, the world's first registered Covid-19 vaccine, have applied for official certification from the World Health Organization (WHO). The groundbreaking Russian vaccine is currently being evaluated in Geneva. Speaking to radio station Echo of Moscow, the WHO's representative in Russia, Melita Vujnovic, explained that…

Read more